Small-molecule switches put therapeutic CRISPR editing under on-demand control in living tissues. In a study published in Science Translational Medicine, a team of researchers led by Dr.
A apuração publicada por phys.org vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: In a study published in Science Translational Medicine, a team of researchers led by Dr. Wang Yu from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences developed PRINCE and Little Prince, dual small-molecule-controlled genome editing systems that allow CRISPR activity to be switched on by drug inducers and kept largely silent in their absence.
- Ponto de atenção: small.
- Ponto de atenção: molecule.
- Ponto de atenção: switches.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Agro. Quando fizer sentido, a referência complementar pode ser acessada em direto do produtor.
:quality(85)/df8a75fd-94c3-446f-bfb2-c74b40466340.png)